FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2053204876> ?p ?o ?g. }

• W2053204876 endingPage "180" @default.
• W2053204876 startingPage "172" @default.
• W2053204876 abstract "In view of the involvement of various neuropeptides and growth factors in the progression of androgen-independent prostate cancer, we investigated the effects of antagonists of growth hormone-releasing hormone (GHRH) alone or in combination with an antagonist of bombesin/gastrin-releasing peptide (BN/GRP) on PC-3 human prostate cancers.Nude mice implanted with PC-3 tumors received GHRH antagonists MZ-5-156 or JV-1-38, each at 20 microgram/day s.c. In experiment 2, treatment consisted of daily injections of JV-1-38 (20 microgram), BN/GRP antagonist RC-3940-II (10 microgram), or a combination of JV-1-38 and RC-3940-II. Serum IGF-I levels, expression of mRNA for IGF-II, and characteristics of BN/GRP and EGF receptors in tumor tissue were investigated.JV-1-38 induced a greater inhibition of tumor growth and suppression of IGF-II mRNA than MZ-5-156, both compounds causing a similar decrease in serum IGF-I. In experiment 2, JV-1-38 and RC-3940-II produced a comparable reduction in tumor volume (65% and 61%, respectively), but a combination of both antagonists augmented tumor inhibition to 75%. Combined treatment with JV-1-38 and RC-3940-II also led to a greater suppression of IGF-II mRNA (92%), as compared with JV-1-38 (72%) or RC-3940-II (77%). Serum IGF-I concentration was lowered only in mice treated with JV-1-38, while the downregulation of BN/GRP and EGF receptors was specific for groups receiving RC-3940-II.The inhibitory effects of GHRH antagonists on PC-3 human androgen-independent prostate cancer can be potentiated by concomitant use of BN/GRP antagonists. The combination of both types of analogs apparently interferes with both IGF and bombesin/EGF pathways, and might be clinically useful for the management of androgen-independent prostate cancer." @default.
• W2053204876 created "2016-06-24" @default.
• W2053204876 creator A5008707617 @default.
• W2053204876 creator A5016033218 @default.
• W2053204876 creator A5063861158 @default.
• W2053204876 creator A5065215059 @default.
• W2053204876 creator A5066730327 @default.
• W2053204876 creator A5067625265 @default.
• W2053204876 creator A5070436482 @default.
• W2053204876 date "2000-01-01" @default.
• W2053204876 modified "2023-10-07" @default.
• W2053204876 title "Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways" @default.
• W2053204876 cites W112693392 @default.
• W2053204876 cites W1600553288 @default.
• W2053204876 cites W1965406729 @default.
• W2053204876 cites W1966050646 @default.
• W2053204876 cites W1967097978 @default.
• W2053204876 cites W1968286492 @default.
• W2053204876 cites W1974027055 @default.
• W2053204876 cites W1974329776 @default.
• W2053204876 cites W198343785 @default.
• W2053204876 cites W1988679331 @default.
• W2053204876 cites W2001483661 @default.
• W2053204876 cites W2020636054 @default.
• W2053204876 cites W2023403785 @default.
• W2053204876 cites W2034986840 @default.
• W2053204876 cites W2037861236 @default.
• W2053204876 cites W2038430386 @default.
• W2053204876 cites W2052899126 @default.
• W2053204876 cites W2060660447 @default.
• W2053204876 cites W2070301852 @default.
• W2053204876 cites W2080629764 @default.
• W2053204876 cites W2087329787 @default.
• W2053204876 cites W2090657739 @default.
• W2053204876 cites W2093397667 @default.
• W2053204876 cites W2142035007 @default.
• W2053204876 cites W2159318197 @default.
• W2053204876 cites W2325047804 @default.
• W2053204876 cites W2417465467 @default.
• W2053204876 doi "https://doi.org/10.1002/1097-0045(20000701)44:2<172::aid-pros10>3.0.co;2-z" @default.
• W2053204876 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10881027" @default.
• W2053204876 hasPublicationYear "2000" @default.
• W2053204876 type Work @default.
• W2053204876 sameAs 2053204876 @default.
• W2053204876 citedByCount "63" @default.
• W2053204876 countsByYear W20532048762012 @default.
• W2053204876 countsByYear W20532048762013 @default.
• W2053204876 countsByYear W20532048762022 @default.
• W2053204876 countsByYear W20532048762023 @default.
• W2053204876 crossrefType "journal-article" @default.
• W2053204876 hasAuthorship W2053204876A5008707617 @default.
• W2053204876 hasAuthorship W2053204876A5016033218 @default.
• W2053204876 hasAuthorship W2053204876A5063861158 @default.
• W2053204876 hasAuthorship W2053204876A5065215059 @default.
• W2053204876 hasAuthorship W2053204876A5066730327 @default.
• W2053204876 hasAuthorship W2053204876A5067625265 @default.
• W2053204876 hasAuthorship W2053204876A5070436482 @default.
• W2053204876 hasConcept C118303440 @default.
• W2053204876 hasConcept C121608353 @default.
• W2053204876 hasConcept C126322002 @default.
• W2053204876 hasConcept C134018914 @default.
• W2053204876 hasConcept C170493617 @default.
• W2053204876 hasConcept C185592680 @default.
• W2053204876 hasConcept C2775960820 @default.
• W2053204876 hasConcept C2776235491 @default.
• W2053204876 hasConcept C2776362946 @default.
• W2053204876 hasConcept C2776885963 @default.
• W2053204876 hasConcept C2776998989 @default.
• W2053204876 hasConcept C2778448772 @default.
• W2053204876 hasConcept C2780192828 @default.
• W2053204876 hasConcept C71924100 @default.
• W2053204876 hasConcept C86803240 @default.
• W2053204876 hasConceptScore W2053204876C118303440 @default.
• W2053204876 hasConceptScore W2053204876C121608353 @default.
• W2053204876 hasConceptScore W2053204876C126322002 @default.
• W2053204876 hasConceptScore W2053204876C134018914 @default.
• W2053204876 hasConceptScore W2053204876C170493617 @default.
• W2053204876 hasConceptScore W2053204876C185592680 @default.
• W2053204876 hasConceptScore W2053204876C2775960820 @default.
• W2053204876 hasConceptScore W2053204876C2776235491 @default.
• W2053204876 hasConceptScore W2053204876C2776362946 @default.
• W2053204876 hasConceptScore W2053204876C2776885963 @default.
• W2053204876 hasConceptScore W2053204876C2776998989 @default.
• W2053204876 hasConceptScore W2053204876C2778448772 @default.
• W2053204876 hasConceptScore W2053204876C2780192828 @default.
• W2053204876 hasConceptScore W2053204876C71924100 @default.
• W2053204876 hasConceptScore W2053204876C86803240 @default.
• W2053204876 hasIssue "2" @default.
• W2053204876 hasLocation W20532048761 @default.
• W2053204876 hasLocation W20532048762 @default.
• W2053204876 hasOpenAccess W2053204876 @default.
• W2053204876 hasPrimaryLocation W20532048761 @default.
• W2053204876 hasRelatedWork W1530797390 @default.
• W2053204876 hasRelatedWork W1980810147 @default.
• W2053204876 hasRelatedWork W1982477928 @default.
• W2053204876 hasRelatedWork W2000249325 @default.
• W2053204876 hasRelatedWork W2024928577 @default.
• W2053204876 hasRelatedWork W2047300206 @default.

• next